# Epithelial Gab1 Restricts Sepsis‐Induced Intestinal Injury by Orchestrating TNF/NF‐κB Axis

**Authors:** Wei Jin, Yanchuang Wu, Xiaoqing Cheng, Yu Pan, Lifeng He, Yun Xu, Jiaqi Xu, Xue Zhang

PMC · DOI: 10.1155/mi/5486971 · 2026-01-31

## TL;DR

Gab1 protects intestinal cells from dying during sepsis by controlling inflammation and maintaining gut barrier function.

## Contribution

Gab1's protective role in sepsis is revealed through its regulation of apoptosis and NF-κB signaling in intestinal epithelial cells.

## Key findings

- Gab1 deficiency in intestinal epithelial cells increases susceptibility to sepsis and apoptosis.
- Gab1 activates NF-κB to regulate apoptotic genes and sustain intestinal homeostasis.
- Restoring Gab1 may offer therapeutic strategies for sepsis management.

## Abstract

A series of intestine‐related alterations have been considered a key factor in triggering sepsis, with increased apoptosis of intestinal epithelial cells (IECs) notably contributing to this process. Compromised gut barrier due to IEC apoptosis promotes bacterial translocation and inflammatory responses, which in turn escalates to further IEC death and barrier defects. Nevertheless, the precise mechanisms that safeguard IECs from apoptosis and interrupt this vicious cycle are yet to be elucidated. Here, we report that Grb2‐associated binder 1 (Gab1) expression is diminished in the intestines of both septic patients and established sepsis models. Epithelial Gab1 deficiency rendered mice susceptible to lipopolysaccharide (LPS)‐induced sepsis by sensitizing IECs to apoptosis, thereby contributing to systemic inflammation and markedly exacerbating septic lethality. Mechanistically, Gab1 mitigated apoptotic signaling via IKKβ‐dependent NF‐κB activation and subsequent transcriptional regulation of apoptotic genes in response to TNF‐α. Collectively, our findings define a protective role for Gab1 in sepsis‐induced intestinal injury by sustaining apoptotic balance and intestinal homeostasis, which provides new insights into therapeutic strategies for sepsis management, particularly those aiming at restoring immune homeostasis and improving barrier function.

## Linked entities

- **Genes:** GAB1 (GRB2 associated binding protein 1) [NCBI Gene 2549], IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta) [NCBI Gene 3551], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790]
- **Proteins:** TNF (tumor necrosis factor)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta) [NCBI Gene 3551] {aka IKK-2, IKK-beta, IKK2, IKKB, IMD15, IMD15A}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, GAB1 (GRB2 associated binding protein 1) [NCBI Gene 2549] {aka DFNB26}
- **Diseases:** inflammation (MESH:D007249), septic (MESH:D001170), Intestinal Injury (MESH:D007410), Sepsis (MESH:D018805)
- **Chemicals:** LPS (MESH:D008070)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Figures

47 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12860144/full.md

---
Source: https://tomesphere.com/paper/PMC12860144